Pentwater Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Pentwater Capital Management’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-240,000	Closed	-$13.4M	–	172
2014 Q4	$13.4M	Sell	240,000 -60,000	-20%	-$3.15M	0.1%	82
2014 Q3	$13.6M	Hold	300,000	–	–	0.13%	86
2014 Q2	$12.4M	Buy	300,000 +250,000	+500%	+$12.9M	0.13%	74
2014 Q1	$3.46M	Sell	50,000 -54,000	-52%	-$3.97M	0.09%	80
2013 Q4	$6.27M	Buy	104,000 +30,000	+41%	+$1.63M	0.18%	71
2013 Q3	$4.5M	Buy	+74,000	New	+$5.25M	0.12%	78

Other funds holding CLVS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return

Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Pentwater Capital Management's CLVS Position: Q1 2015 in Review

Pentwater Capital Management sold out of Clovis Oncology, Inc. (CLVS) in Q1 2015, closing a stake of 494,600 shares — an estimated $27.7M sold.

Pentwater Capital Management first reported a position in CLVS in Q4 2013 and held it in 5 quarters. The position peaked at $29.5M in Q3 2014. 152 funds tracked by Wall St. Rank hold CLVS as of Q1 2015.

Pentwater Capital Management reported no remaining Clovis Oncology, Inc. position as of Q1 2015 after selling out during the quarter.
Pentwater Capital Management sold 494,600 Clovis Oncology, Inc. shares in Q1 2015, an estimated $27.7M.
Pentwater Capital Management first reported a position in Clovis Oncology, Inc. in Q4 2013 and held it in 5 quarters.
Pentwater Capital Management's Clovis Oncology, Inc. position peaked at $29.5M in Q3 2014.
152 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2015.

Based on Pentwater Capital Management's 13F filing for Q1 2015, filed 15 May 2015.